Home › XELJANZ (Tofacitinib Citrate) Approved In Japan For The Treatment Of Adults With Rheumatoid Arthritis (RA)
 

Keywords :   


XELJANZ (Tofacitinib Citrate) Approved In Japan For The Treatment Of Adults With Rheumatoid Arthritis (RA)

2013-03-25 08:00:00| drugdiscoveryonline News Articles

Pfizer Inc. announced recently that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved XELJANZ (tofacitinib citrate) for the treatment of adults with rheumatoid arthritis (RA) who have had an inadequate response to existing therapies

Tags: with japan treatment approved

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.11Online slots gambling to be limited to 5 per spin
27.11H0599bikke8.7AH
27.11 staff
27.11 TWINS 8oz
27.11
27.1120194
27.11V 7
27.1120th
More »